A detailed history of Trexquant Investment LP transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 294,201 shares of AUPH stock, worth $1.68 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
294,201
Holding current value
$1.68 Million
% of portfolio
0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$4.93 - $9.31 $1.45 Million - $2.74 Million
294,201 New
294,201 $1.47 Million
Q3 2023

Nov 13, 2023

SELL
$7.77 - $12.27 $2.06 Million - $3.26 Million
-265,615 Reduced 83.0%
54,403 $422,000
Q2 2023

Aug 11, 2023

BUY
$8.96 - $11.69 $1.21 Million - $1.57 Million
134,576 Added 72.57%
320,018 $3.1 Million
Q1 2023

May 15, 2023

BUY
$5.94 - $11.27 $520,450 - $987,454
87,618 Added 89.57%
185,442 $2.03 Million
Q4 2022

Feb 13, 2023

SELL
$4.11 - $8.14 $20,993 - $41,579
-5,108 Reduced 4.96%
97,824 $422,000
Q3 2022

Nov 14, 2022

BUY
$6.66 - $12.39 $393,346 - $731,765
59,061 Added 134.62%
102,932 $774,000
Q2 2022

Aug 11, 2022

BUY
$8.95 - $12.8 $392,645 - $561,548
43,871 New
43,871 $441,000
Q1 2022

May 13, 2022

SELL
$10.05 - $22.48 $213,160 - $476,800
-21,210 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$17.78 - $33.08 $377,113 - $701,626
21,210 New
21,210 $485,000
Q3 2021

Nov 12, 2021

SELL
$10.93 - $23.55 $283,742 - $611,358
-25,960 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$10.0 - $14.52 $96,880 - $140,669
-9,688 Reduced 27.18%
25,960 $336,000
Q1 2021

May 13, 2021

BUY
$12.3 - $18.73 $438,470 - $667,687
35,648 New
35,648 $463,000
Q4 2020

Feb 11, 2021

SELL
$12.94 - $16.05 $246,908 - $306,250
-19,081 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$13.19 - $16.66 $251,678 - $317,889
19,081 New
19,081 $281,000
Q1 2020

May 08, 2020

SELL
$11.34 - $21.46 $751,887 - $1.42 Million
-66,304 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$3.88 - $21.42 $257,259 - $1.42 Million
66,304 New
66,304 $1.34 Million

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $810M
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.